secwatch.observer — SEC 8-K summary
======================================

Issuer:     Relay Therapeutics, Inc. (RLAY)
CIK:        0001812364
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001193125-25-137162
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Relay Therapeutics stockholders elect directors and approve auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Alexis Borisy elected class II director with 80.7M votes for, 43.0M withheld.
- Mark Murcko elected class II director with 79.5M votes for, 44.2M withheld.
- Non-binding advisory vote on executive compensation approved: 69.7M for, 53.9M against.
- Ratification of Ernst & Young as auditor for FY2025 passed with 142.2M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812364/000119312525137162/0001193125-25-137162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812364/000119312525137162/d48764d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-137162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer